Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses ABEO in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ABEO in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Vishwas Seshadri | $662,000 | $533,333 | $2,472,698 | $0 | $309,485 | $0 | $14,000 | $3,991,516 |
| President and Chief Executive Officer | ||||||||
| Joseph Vazzano | 475,903 | 235,333 | 836,400 | 0 | 173,229 | 0 | 14,000 | 1,734,865 |
| Chief Financial Officer | ||||||||
| Brendan O’Malley | 456,435 | 150,000 | 600,000 | 0 | 163,491 | 0 | 14,000 | 1,383,926 |
| Chief Legal Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Vishwas Seshadri | $3,991,516 | $3,506,708 | — | +484,808 |
| Joseph Vazzano | 1,734,865 | 1,633,999 | — | +100,866 |
| Brendan O’Malley | 1,383,926 | 1,270,436 | — | +113,490 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Joseph Vazzano | RSA | 2022-07-02 | — | — | 12,000 | — | — |
Grant-level vehicle detail not disclosed.
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Vishwas Seshadri | RSU | 144,509 | — | $761,562 |
| Joseph Vazzano | RSU | 115,607 | — | 609,249 |
| Vishwas Seshadri | RSU | 112,276 | — | 591,695 |
| Vishwas Seshadri | RSU | 103,467 | — | 545,269 |
| Joseph Vazzano | RSU | 68,460 | — | 360,784 |
| Joseph Vazzano | RSU | 47,303 | — | 249,285 |
| Vishwas Seshadri | RSU | 38,800 | — | 204,476 |
| Joseph Vazzano | RSU | 30,301 | — | 159,685 |
| Joseph Vazzano | RSU | 18,186 | — | 95,840 |
| Vishwas Seshadri | RSU | 13,333 | — | 70,265 |
| Joseph Vazzano | RSU | 3,000 | — | 15,810 |
| Joseph Vazzano | RSU | 2,000 | — | 10,540 |
The Company's compensation program is designed to attract, retain, and motivate highly qualified executives by providing competitive base salaries, annual discretionary bonuses, and long-term equity incentives that align executive interests with stockholder value. The Compensation Committee aims to avoid granting equity awards in anticipation of material non-public information and does not currently grant stock options.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Radford, a unit of Aon plc |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-12 | 23,300,653 | 4,511,866 | 1,916,542 | 83.78% | Passed |
| 2025 | 2025-05-19 | 25,777,223 | 1,552,881 | 105,031 | 94.32% | Passed |
| 2023 | 2023-05-17 | 6,436,890 | 282,439 | 36,768 | 95.8% | Passed |
| 2022 | 2022-08-17 | 1,260,149 | 371,509 | 24,144 | 77.23% | Passed |
| 2019 | 2019-05-28 | 30,603,677 | 635,820 | 319,261 | 97.96% | Passed |
| 2016 | 2016-05-12 | 18,638,144 | 116,972 | 19,163 | 99.38% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-12 | 83.78%a |
| 2025 | 2025-05-19 | 94.32%b |
| 2023 | 2023-05-17 | 95.8%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 15,000 |
| Stock ownership guideline | — |
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Abeona Therapeutics | 2025 | Vishwas Seshadri | $662,000 | $2,472,698 | $0 | $309,485 | $3,991,516 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Vishwas Seshadri | DEF 14A | 2026-04-27 | 0001493152-26-019153 | Section “Executive Compensation”. As printed: 3,991,516. Filing ↗ |
| 2 | Section 01, Joseph Vazzano | DEF 14A | 2026-04-27 | 0001493152-26-019153 | Section “Executive Compensation”. As printed: 1,734,865. Filing ↗ |
| 3 | Section 01, Brendan O’Malley | DEF 14A | 2026-04-27 | 0001493152-26-019153 | Section “Executive Compensation”. As printed: 1,383,926. Filing ↗ |
| 4 | Section 03, Joseph Vazzano RSA | DEF 14A | 2026-04-27 | 0001493152-26-019153 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 399423–399429 |
| 5 | Section 06, 2026 vote | Form 8-K | 2026-06-12 | 0001493152-26-028458 | Item 5.07 · say-on-pay result. As reported: 83.78% (votes for as printed: 23,300,653). Filing ↗ |
| 6 | Section 06, 2025 vote | Form 8-K | 2025-05-19 | 0001641172-25-011452 | Item 5.07 · say-on-pay result. As reported: 94.32% (votes for as printed: 25,777,223). Filing ↗ |
| 7 | Section 06, 2023 vote | Form 8-K | 2023-05-17 | 0001493152-23-017946 | Item 5.07 · say-on-pay result. As reported: 95.8% (votes for as printed: 6,436,890). Filing ↗ |
| 8 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 9 | Abeona Therapeutics (subject), Section 10b CEO total | DEF 14A | 2026-04-27 | 0001493152-26-019153 | CEO total compensation as printed in Abeona Therapeutics's own proxy. As printed: 3,991,516. Filing ↗ |